Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN)

CUSIP: 86889P208

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock, $0.0001 par value per share
Total 13F shares
6,756,528
Total 13F value
$151,363,201
Holder snapshot 6 signals
Share change
+1,375,448
SEC-reported price per share
$22.60
Number of holders
53
Value change
+$40,461,119
Number of buys
38
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,053,283

Security key

86889P208

Report period

Q4 2025

Institutions

53

Top holders

10

SRZN full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Surrozen, Inc./DE SEC filings Surrozen, Inc./DE company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AI Biotechnology LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 9.9% 13D/G row: AI Biotechnology LLC Showing 1-6 of 15 holder rows.

Quick read

AI Biotechnology LLC leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AI Biotechnology LLC's linked filing trail.
Comparable ownership Top 5
AI Biotechnology LLC 9.9%
RA CAPITAL MANAGEMENT, L.P. 9.2%
INTEGRATED CORE STRATEGIES (US) LLC 8.5%
BRAIDWELL LP 5.5%
Stonepine Capital Management, LLC 3.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AI Biotechnology LLC
13D/G
13D/G
9.9%
$8,462,521
844,563 shares
 $0 24 Mar 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
13D/G 13F
9.2%
$18,001,245
871,731 shares
 +$89,063 31 Dec 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
13D/G
8.5%
$15,649,459
726,193 shares
 +$3,477,006 31 Dec 2025
BRAIDWELL LP
13D/G 13F
Company
13D/G 13F
5.5%
$9,705,500
470,000 shares
 $0 31 Dec 2025
Stonepine Capital Management, LLC
13D/G 13F
Company
13D/G 13F
3.6%
$6,531,368
316,289 shares
 -$3,973,019 31 Dec 2025
Nantahala Capital Partners Limited Partnership
13D/G
13D/G
2.2%
$740,658
73,918 shares
 -$1,032,581 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
53
Shares
6,756,528
Rows available
53
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
35
Q4 2025 holders
53
Holder diff
18
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .